Key information about NTNU and its academic surroundings
NTNU is Norway's second largest university, with an annual budget of about US $800 million. It graduates about 3,300 students every year, two-thirds of which are master's or PhD's.The university has more than 100 laboratory facilities distributed among the different faculties and departments, including core facilities for genome sequencing, metabolomics and proteomics.
NTNU has the primary responsibility for higher engineering education in Norway, and is the second largest provider of teacher candidates.NTNU has four facilitating technology streams underlying its R&D and education: ICT, materials, nanotechnology and biotechnology. NTNU has a strong track record of medical technology development through close collaboration between the Engineering faculties and the Medical faculty.
The host faculty for the VPH2014 conference is the Faculty of Medicine. Some of its outstanding research centres are:
- The Kavli Institute for Systems Neuroscience; the search for basic principles of the brain's network, focused on sense of locality and memory.
- K. G. Jebsen Center of Exercise in Medicine: Identification of central cellular and molecular mechanisms involved in physical training. Main focus on effects on the heart, blood vessels and skeletal muscles. Combines experimental, clinical and epidemiological studies.
- K.G. Jebsen Center of Myelomatosis; Identification of biological subgroups of disease to facilitate more individual treatments of patients.
- Newly appointed Centre of Excellence: Centre of Molecular Inflammation Research. The centre will identify new diagnostic tools and therapeutic targets for inflammatory diseases that will lead to a greater understanding of how the body's inflammatory responses to disease are triggered and how the immune system is activated.
- Medical Imaging: One of the network groups in the NTNU's strategic area of Medical Technology. This network includes researchers who contributed substantially to the ultrasound doppler technique that is now used in advanced biomedical ultrasound equipment.
NTNU is in possession of the biobank HUNT (The Nord-Trøndelag health study). It is one of the largest health studies ever performed. It is a unique database of personal and family medical histories collected during three intensive studies. HUNT 1 was carried out in 1984-1986 to establish the health history of 75,000 people. HUNT 2, carried out in 1995-1997, focused on the evolution of the health history of 74,000 people. This included blood sample collection from 65,000 people. The data that accompany biospecimens in the biobank are stored in secured computer systems that run complex database management and analysis software. HUNT 3 was completed in June 2008. 93,210 people were invited to participate in the study, and as of the 6th of June, 2008, 48,289 people participated (52% participation rate). The data, collected by means of questionnaires, interviews, clinical examinations and collection of blood and urine samples, have been available since January 2009. Today, HUNT is a database with information about approximately 120,000 people that integrates family data and individual data and can be linked to national health registries. The HUNT study is reinforced and supplemented by cross-referencing with registries at the regional level (Registries such as radial and hip fractures, venous thrombosis, lung embolism, ischemic heart disease and stroke) and with registries at the national level (The Cancer Register, The Medical Birth Register, and The National Health Insurance Register). Additionally, Statistics Norway provides necessary information from The Population Census Register and The Family Register to create a genealogical database ("family trees"). Plans are now made for initiating HUNT 4 with a clear intention of tuning the data collection to the needs of computational physiology.
St. Olavs Hospital, Trondheim University Hospital, is integrated with The Faculty of Medicine at NTNU and is owned by the Central Norway Regional Health Authority. St. Olavs Hospital is one of Europe's most modern university hospitals and employs about 9000 people. In the last decade the university hospital has been re-built, with brand new buildings and facilities at a cost of about 2 billion dollars. As an integrated University Hospital it has medical doctors, nurses, medical students and researchers working in all of the buildings at the hospital. The main tasks of the Hospital are patient treatment, teaching of patients and their relatives, translational research, and education for health professionals. The hospital is focused on creating value through knowledge generation, research and innovation, and the development of technological solutions that are brought into practical use.
SINTEF (www.sintef.no), the largest independent research organization in Scandinavia (comprising 2100 staff), operates in partnership with the Norwegian University of Science and Technology (NTNU). It is a broadly based, multidisciplinary research organization that possesses international top-level expertise in technology, medicine and the social sciences. NTNU personnel work on SINTEF projects, while many SINTEF staff teaches at NTNU. The collaboration involves the extensive joint use of laboratories and equipment, and more than 500 people are employed by both NTNU and SINTEF. The Gemini centres represent a strategic collaboration model where research groups or centres at the university and SINTEF can manage their common resources together.
The newly launched NTNU biotechnology initiative, "NTNU Biotechnology – the Confluence of Life Sciences, Mathematical Sciences and Engineering", involves six of the university's eight faculties. One of its stated missions is to make substantial contributions to the VPH vision in close collaboration with St. Olavs Hospital, SINTEF and the international VPH community.